Thrombocytopenia and severe hyperbilirubinemia in the neonatal period secondary to congenital thrombotic thrombocytopenic purpura and ADAMTS13 deficiency

被引:17
|
作者
Schiff, DE
Roberts, WD
Willert, J
Tsai, HM
机构
[1] Childrens Hosp San Diego, Div Hematol Oncol, San Diego, CA 92123 USA
[2] Montefiore Med Ctr, Div Hematol, Bronx, NY 10467 USA
[3] Albert Einstein Coll Med, Bronx, NY 10467 USA
关键词
ADAMTS13; deficiency; congenital thrombotic thrombocytopenic; purpura; congenital hemolytic anemia; hyperbilirubinemia; thrombocytopenia;
D O I
10.1097/01.mph.0000135284.85292.2c
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Congenital thrombotic thrombocytopenic purpura (TTP) is an inherited form of TTP due to the deficiency of von Willebrand factor (vWF) cleaving protease ADAMTS13. The authors describe two children with congenital TTP who presented with thrombocytopenia, hemolytic anemia, elevated LDH levels, and schistocytes on peripheral blood smear. In both children, the diagnosis of the disease was delayed despite neonatal histories significant for thrombocytopenia, anemia, and severe hyperbilirubinemia. Severely decreased ADAMTS 13 activity (<0. I U/mL), the absence of an inhibitor to the protease, and partial deficiency found in the parents confirmed the diagnosis of congenital TTP. The authors suggest that congenital TTP should be considered in the differential diagnosis for newborns presenting with severe hyperbilirubinemia, anemia, and thrombocytopenia.
引用
收藏
页码:535 / 538
页数:4
相关论文
共 50 条
  • [41] Molecular basis of ADAMTS13 dysfunction in thrombotic thrombocytopenic purpura
    Minola Manea
    Diana Karpman
    Pediatric Nephrology, 2009, 24 : 447 - 458
  • [42] Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura
    Sadler, J. Evan
    BLOOD, 2008, 112 (01) : 11 - 18
  • [43] ADAMTS13 Biomarkers in Management of Immune Thrombotic Thrombocytopenic Purpura
    Sui, Jingrui
    Zheng, Liang
    Zheng, X. Long
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2023, 147 (08) : 974 - 979
  • [44] Advantages and limits of ADAMTS13 testing in thrombotic thrombocytopenic purpura
    Franchini, Massimo
    Mannucci, Pier Mannuccio
    BLOOD TRANSFUSION, 2008, 6 (03) : 127 - 135
  • [45] Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura
    Han-Mou Tsai
    Journal of Molecular Medicine, 2002, 80 : 639 - 647
  • [46] Identification of novel mutations in ADAMTS13 in an adult patient with congenital thrombotic thrombocytopenic purpura
    Uchida, T
    Wada, H
    Mizutani, M
    Iwashita, M
    Ishihara, H
    Shibano, T
    Suzuki, M
    Matsubara, Y
    Soejima, K
    Matsumoto, M
    Fujimura, Y
    Ikeda, Y
    Murata, M
    BLOOD, 2004, 104 (07) : 2081 - 2083
  • [47] Normal Lymphocyte Count is Characteristic of Thrombotic Thrombocytopenic Purpura Patients with ADAMTS13 Deficiency
    Li, G.
    Reeves, H. M.
    Maitta, R. W.
    TRANSFUSION, 2015, 55 : 117A - 117A
  • [48] Deficiency of ADAMTS-13 in thrombotic and thrombocytopenic purpura
    Tsai, HM
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (09) : 2038 - 2040
  • [49] ADAMTS13 Antibody Depletion by Bortezomib in Thrombotic Thrombocytopenic Purpura
    Shortt, Jake
    Oh, Danielle H.
    Opat, Stephen S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (01): : 90 - 92
  • [50] Molecular basis of ADAMTS13 dysfunction in thrombotic thrombocytopenic purpura
    Manea, Minola
    Karpman, Diana
    PEDIATRIC NEPHROLOGY, 2009, 24 (03) : 447 - 458